TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
The post TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace